enow.com Web Search

  1. Ads

    related to: breast cancer hormone therapy postmenopausal women with alcohol withdrawal

Search results

  1. Results from the WOW.Com Content Network
  2. Alcohol and breast cancer - Wikipedia

    en.wikipedia.org/wiki/Alcohol_and_breast_cancer

    Even light consumption of alcohol – one to three drinks per week – increases the risk of breast cancer. [3] Heavy drinkers are also more likely to die from breast cancer than non-drinkers and light drinkers. [3] [7] Also, the more alcohol a woman consumes, the more likely she is to be diagnosed with a recurrence after initial treatment. [7]

  3. Side effects of cyproterone acetate - Wikipedia

    en.wikipedia.org/wiki/Side_effects_of_cyprotero...

    The Women's Health Initiative randomized controlled trials demonstrated a significantly increased risk of breast cancer with 0.625 mg/day conjugated estrogens and 2.5 mg/day medroxyprogesterone acetate (a progestin closely related to CPA) for menopausal hormone therapy relative to 0.625 mg/day conjugated estrogens alone and placebo in peri-and ...

  4. Alcohol and cancer - Wikipedia

    en.wikipedia.org/wiki/Alcohol_and_cancer

    A woman drinking an average of two units of alcohol per day has an 8% higher risk of developing breast cancer than a woman who drinks an average of one unit of alcohol per day. [60] A study concluded that for every additional drink regularly consumed per day, the incidence of breast cancer increases by 11 per 1000. [47]

  5. Hormonal therapy (oncology) - Wikipedia

    en.wikipedia.org/wiki/Hormonal_therapy_(oncology)

    Tamoxifen is currently first-line treatment for nearly all pre-menopausal women with hormone receptor-positive breast cancer. [1] Raloxifene is another partial agonist SERM which does not seem to promote endometrial cancer, and is used primarily for chemoprevention of breast cancer in high-risk individuals, as well as to prevent osteoporosis. [1]

  6. Aromatase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Aromatase_inhibitor

    Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [1] [2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.

  7. What are the signs you need hormone replacement therapy ... - AOL

    www.aol.com/signs-hormone-replacement-therapy...

    Hormone replacement therapy could be a major key to unlocking health benefits for women going through menopause, according to new research.. A study published Aug. 29 in the journal JAMA Network ...

  8. Estrogen deprivation therapy - Wikipedia

    en.wikipedia.org/wiki/Estrogen_deprivation_therapy

    Estrogen deprivation therapy, also known as endocrine therapy, is a form of hormone therapy that is used in the treatment of breast cancer.Modalities include antiestrogens or estrogen blockers such as selective estrogen receptor modulators (SERMs) like tamoxifen, selective estrogen receptor degraders like fulvestrant, and aromatase inhibitors like anastrozole and ovariectomy.

  9. Olivia Munn is going through medically induced menopause ...

    www.aol.com/lifestyle/olivia-munn-going...

    Olivia Munn is in medically induced menopause as a result of treatment to keep her breast cancer from recurring, the actress told People in an exclusive new interview. Munn, who last month ...

  1. Ads

    related to: breast cancer hormone therapy postmenopausal women with alcohol withdrawal
  1. Related searches breast cancer hormone therapy postmenopausal women with alcohol withdrawal

    alcohol and breast canceralcohol and cancer in pregnancy
    oncology hormone therapyalcohol and cancer